Does ERLOTINIB Cause Interstitial lung disease? 116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Interstitial lung disease have been filed in association with ERLOTINIB (Erlotinib). This represents 0.5% of all adverse event reports for ERLOTINIB.
116
Reports of Interstitial lung disease with ERLOTINIB
0.5%
of all ERLOTINIB reports
47
Deaths
43
Hospitalizations
How Dangerous Is Interstitial lung disease From ERLOTINIB?
Of the 116 reports, 47 (40.5%) resulted in death, 43 (37.1%) required hospitalization, and 11 (9.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ERLOTINIB.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Off label use (1,190)
Decreased appetite (998)
Malignant neoplasm progression (954)
Dry skin (953)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ERLOTINIB Alternatives Have Lower Interstitial lung disease Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE